Exane Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-82,881	Closed	-$8.04M	–	121
2018 Q3	$8.04M	Sell	82,881 -32,305	-28%	-$3.22M	2.52%	15
2018 Q2	$10.9M	Sell	115,186 -17,881	-13%	-$1.57M	4.7%	6
2018 Q1	$10.8M	Sell	133,067 -28,122	-17%	-$2.41M	3.24%	11
2017 Q4	$14.4M	Buy	161,189 +40,989	+34%	+$3.56M	4.46%	10
2017 Q3	$11.2M	Buy	+120,200	New	+$10.6M	2.19%	18
2017 Q1	–	Sell	-101,548	Closed	-$8.41M	–	39
2016 Q4	$8.41M	Sell	101,548 -28,990	-22%	-$2.49M	2.77%	17
2016 Q3	$12.1M	Sell	130,538 -32,684	-20%	-$3.08M	3.79%	10
2016 Q2	$12.7M	Buy	163,222 +17,402	+12%	+$1.48M	4.93%	8
2016 Q1	$12M	Buy	+145,820	New	+$11.9M	6.26%	5